Kowa Research Institute, Inc.
Clinical trials sponsored by Kowa Research Institute, Inc., explained in plain language.
-
New hope for bile duct disease: experimental drug K-808 tested in patients failed by standard care
Disease control OngoingThis study tests whether a new drug called K-808 (Pemafibrate) can improve liver health in people with primary biliary cholangitis (PBC), a chronic liver disease. The trial includes 46 adults whose disease did not respond well to standard medications. Participants receive either …
Phase: PHASE2 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated May 17, 2026 05:30 UTC
-
New drug cocktail aims to halt liver scarring in NASH patients
Disease control OngoingThis study tests whether a combination of two experimental drugs can improve liver health in adults with NASH, a fatty liver disease that can lead to scarring. About 228 participants with mild to moderate liver scarring will take the drugs for up to a year. The main goal is to se…
Phase: PHASE2 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC